Search research articles
Contact Us
Filters
Showing results (841-850 of 943) with videos related to
Page
of 95
Sort By:
The Journal of Infectious Diseases
|
July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum
Laura M Smeaton, Emma M Kileel, Beatriz Grinsztejn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2023
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)
Emma M Kileel, Carlos D Malvestutto, Janet Lo, et al.
AIDS (London, England)
|
June 21, 2024
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV
Samuel R Schnittman, Ria Talathi, Moses Q Wilks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2021
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial
Pamela S Douglas, Triin Umbleja, Gerald S Bloomfield, et al.
Blood Advances
|
January 10, 2024
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial
Romit Bhattacharya, Md Mesbah Uddin, Aniruddh P Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2025
Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2
Steven K Grinspoon, Sophia Zhao, Esteban Martinez, et al.
Mechanisms of Ageing and Development
|
June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment
Chiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
The Lancet. Oncology
|
May 17, 2014
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti, et al.
JACC. Advances
|
May 15, 2025
Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy
Michael T Lu, Heather J Ribaudo, Sara McCallum, et al.
American Journal of Human Genetics
|
September 27, 2016
TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy
Antonella Sferra, Gilbert Baillat, Teresa Rizza, et al.
Page
of 95
Search research articles
Search
Showing results (841-850 of 943) with videos related to
Sort By:
Page
of 95
The Journal of Infectious Diseases
|
July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum
Laura M Smeaton, Emma M Kileel, Beatriz Grinsztejn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2023
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)
Emma M Kileel, Carlos D Malvestutto, Janet Lo, et al.
AIDS (London, England)
|
June 21, 2024
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV
Samuel R Schnittman, Ria Talathi, Moses Q Wilks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2021
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial
Pamela S Douglas, Triin Umbleja, Gerald S Bloomfield, et al.
Blood Advances
|
January 10, 2024
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial
Romit Bhattacharya, Md Mesbah Uddin, Aniruddh P Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2025
Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2
Steven K Grinspoon, Sophia Zhao, Esteban Martinez, et al.
Mechanisms of Ageing and Development
|
June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment
Chiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
The Lancet. Oncology
|
May 17, 2014
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti, et al.
JACC. Advances
|
May 15, 2025
Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy
Michael T Lu, Heather J Ribaudo, Sara McCallum, et al.
American Journal of Human Genetics
|
September 27, 2016
TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy
Antonella Sferra, Gilbert Baillat, Teresa Rizza, et al.
Page
of 95